Cytokinetics
CYTKCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Cytokinetics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/25/2024 | Sell | Henderson, John T. | Director | $64.5 | $681,671 |
| 4/9/2024 | Sell | Malik, Fady Ibraham | EVP Research & Development | $74.3 | $2,422,918 |
| 3/5/2024 | Sell | Malik, Fady Ibraham | EVP Research & Development | $67.6 | $2,202,606 |
| 2/14/2024 | Sell | Henderson, John T. | Director | $76.5 | $382,400 |
| 2/13/2024 | Sell | Blum, Robert I. | President & CEO | $76.9 | $960,625 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)